DUSP6
DUSP6 (dual specificity phosphatase 6, also known as MKP-3 and PYST1) is a cytoplasmic dual specificity phosphatase that dephosphorylates and inactivates MAP kinases, with a preference for the ERK family. It belongs to the MAP kinase phosphatase group. Browse Assay Genie's current range of DUSP6 research reagents below, or read on for the biology behind the target.
DUSP6 is a dual specificity protein phosphatase that mediates dephosphorylation and inactivation of MAP kinases. Dual specificity phosphatases remove phosphate from both phosphoserine/threonine and phosphotyrosine residues, and so act as negative regulators of the MAP kinase superfamily (MAPK/ERK, SAPK/JNK and p38), which are associated with cellular proliferation and differentiation. DUSP6 shows a specificity for the ERK family and inactivates ERK2. It promotes cell differentiation by regulating MAPK1/MAPK3 activity and the expression of AP1 transcription factors.
The DUSP6 protein is also important in pain biology. It is necessary for the normal dephosphorylation of the long-lasting phosphorylated forms of spinal MAPK1/3 and p38 induced by peripheral surgery, which drives the resolution of acute postoperative allodynia. Dephosphorylation of MAPK1/3 in local wound tissue further contributes to the resolution of acute pain, and DUSP6 therefore plays a role in alleviating chronic postoperative pain.
The DUSP6 gene encodes a member of the non-receptor class dual specificity subfamily of the protein-tyrosine phosphatase family. Family members differ in MAP kinase substrate specificity, tissue distribution, subcellular localisation and inducibility by extracellular stimuli. DUSP6 is expressed in a variety of tissues, with the highest levels in heart and pancreas, and unlike most other family members it is localised in the cytoplasm. Mutations in the gene have been associated with congenital hypogonadotropic hypogonadism, and alternatively spliced transcript variants have been described. Mouse and rat orthologs are both named Dusp6.
DUSP6 inactivates ERK2 and shows specificity for the ERK family, making it a key negative regulator of MAPK signalling.
DUSP6 dephosphorylates spinal and wound-tissue MAPK1/3 and p38, driving resolution of acute postoperative allodynia and helping limit chronic postoperative pain.
DUSP6 promotes differentiation by regulating MAPK1/MAPK3 activity and the expression of AP1 transcription factors.
Mutations in DUSP6 have been associated with congenital hypogonadotropic hypogonadism, linking this phosphatase to human disease genetics.
DUSP6 is a dual specificity phosphatase that dephosphorylates and inactivates MAP kinases, with specificity for the ERK family. Through MAPK1/3 regulation it promotes cell differentiation and contributes to the resolution of acute postoperative pain. Check the datasheet of any product for its validated reactivity.
DUSP6 is also called MKP-3 (MAP kinase phosphatase 3) and PYST1. Its full name is dual specificity phosphatase 6, and it is grouped with the MAP kinase phosphatases. Alternatively spliced transcript variants have been reported for the gene.
Mouse and rat both carry a Dusp6 ortholog. In humans, mutations in the DUSP6 gene have been associated with congenital hypogonadotropic hypogonadism. The protein is expressed in many tissues, with the highest levels in heart and pancreas.
Other dual specificity phosphatases and MAP kinase regulators with related research reagents at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16828; product specifications from Assay Genie datasheets.